572 related articles for article (PubMed ID: 16030277)
1. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.
Ridker PM; Rifai N; Cook NR; Bradwin G; Buring JE
JAMA; 2005 Jul; 294(3):326-33. PubMed ID: 16030277
[TBL] [Abstract][Full Text] [Related]
2. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
Mora S; Buring JE; Ridker PM; Cui Y
Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
[TBL] [Abstract][Full Text] [Related]
3. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
Everett BM; Kurth T; Buring JE; Ridker PM
J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
[TBL] [Abstract][Full Text] [Related]
5. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
Ridker PM; Stampfer MJ; Rifai N
JAMA; 2001 May; 285(19):2481-5. PubMed ID: 11368701
[TBL] [Abstract][Full Text] [Related]
6. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.
Mora S; Lee IM; Buring JE; Ridker PM
JAMA; 2006 Mar; 295(12):1412-9. PubMed ID: 16551713
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
Suk Danik J; Rifai N; Buring JE; Ridker PM
JAMA; 2006 Sep; 296(11):1363-70. PubMed ID: 16985228
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
[TBL] [Abstract][Full Text] [Related]
9. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
[TBL] [Abstract][Full Text] [Related]
10. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study.
Ndumele CE; Matsushita K; Astor B; Virani SS; Mora S; Williams EK; Hoogeveen RC; Blumenthal RS; Sharrett AR; Ballantyne CM; Coresh J
Eur J Prev Cardiol; 2014 Jul; 21(7):866-75. PubMed ID: 23109406
[TBL] [Abstract][Full Text] [Related]
11. Sex-Related Differences of the Effect of Lipoproteins and Apolipoproteins on 10-Year Cardiovascular Disease Risk; Insights from the ATTICA Study (2002-2012).
Kouvari M; Panagiotakos DB; Chrysohoou C; Georgousopoulou EN; Tousoulis D; Pitsavos AC
Molecules; 2020 Mar; 25(7):. PubMed ID: 32225033
[TBL] [Abstract][Full Text] [Related]
12. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.
Boekholdt SM; Arsenault BJ; Mora S; Pedersen TR; LaRosa JC; Nestel PJ; Simes RJ; Durrington P; Hitman GA; Welch KM; DeMicco DA; Zwinderman AH; Clearfield MB; Downs JR; Tonkin AM; Colhoun HM; Gotto AM; Ridker PM; Kastelein JJ
JAMA; 2012 Mar; 307(12):1302-9. PubMed ID: 22453571
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
[TBL] [Abstract][Full Text] [Related]
14. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
[TBL] [Abstract][Full Text] [Related]
15. Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.
Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shishido K; Takahashi K; Hosaka N; Ikeda M; Sanada D; Shibata T
PLoS One; 2017; 12(5):e0177980. PubMed ID: 28542510
[TBL] [Abstract][Full Text] [Related]
16. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
[TBL] [Abstract][Full Text] [Related]
17. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
Oyelola OO
Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
[TBL] [Abstract][Full Text] [Related]
18. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
[TBL] [Abstract][Full Text] [Related]
20. Lipid-related markers and cardiovascular disease prediction.
; Di Angelantonio E; Gao P; Pennells L; Kaptoge S; Caslake M; Thompson A; Butterworth AS; Sarwar N; Wormser D; Saleheen D; Ballantyne CM; Psaty BM; Sundström J; Ridker PM; Nagel D; Gillum RF; Ford I; Ducimetiere P; Kiechl S; Koenig W; Dullaart RP; Assmann G; D'Agostino RB; Dagenais GR; Cooper JA; Kromhout D; Onat A; Tipping RW; Gómez-de-la-Cámara A; Rosengren A; Sutherland SE; Gallacher J; Fowkes FG; Casiglia E; Hofman A; Salomaa V; Barrett-Connor E; Clarke R; Brunner E; Jukema JW; Simons LA; Sandhu M; Wareham NJ; Khaw KT; Kauhanen J; Salonen JT; Howard WJ; Nordestgaard BG; Wood AM; Thompson SG; Boekholdt SM; Sattar N; Packard C; Gudnason V; Danesh J
JAMA; 2012 Jun; 307(23):2499-506. PubMed ID: 22797450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
